-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

802.P1.37 802. Chemical Biology and Experimental Therapeutics: Poster I

Symposia: Chemical Biology and Experimental Therapeutics Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Haojie Dong, PhD1*, Xin He, MD2*, Lei Zhang, MD1, Wei Chen, PhD3*, Yichun Lin, MS4*, Songbai Liu, PhD5*, Huafeng Wang, M.D.6*, Wenfeng Huang, MS1*, Sierra Min Li, PhD7*, Yinghui Zhu, PhD8*, Dandan Zhao, MD1*, Lucy Ghoda, PhD9*, Rui Su, PhD10, Jianjun Chen, PhD10, Ritin Sharma11,12*, Patrick Pirrotte, PhD11,12*, Xiwei Wu, PhD3*, Weidong Hu, PhD13*, Weidong Han14*, Binghui Shen, PhD15*, Ya-Huei Kuo, PhD1, Jie Jin, M.D., Ph.D.6, Amandeep Salhotra, MD16, Jeffrey Wang, PhD4*, Guido Marcucci, MD16,17, Yun Luo, PhD4* and Ling Li, PhD18

1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
2Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Monrovia, CA
3Integrative Genomics Core, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
4Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA
5Suzhou Key Laboratory of Medical Biotechnology, Suzhou Vocational Health College, Suzhou, China
6Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China, Hangzhou, China
7Department of Information Sciences, City of Hope Medical Center, Duarte
8Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope, Duarte, CA
9Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope, Duarte, CA
10Department of Systems Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
11AIntegrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, CA
12Cancer & Cell Biology Division, The Translational Genomics Research Institute, Phoenix, AZ
13Department of Immunology & Theranostics, City of Hope National Medical Center, DUARTE, CA
14Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China
15Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, CA
16Department of Hematology and HCT, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
17Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
18Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Jonathan Scott Rink, PhD1,2*, Stephen E Henrich, PhD1*, Alexandra Moxley3*, Xu Hannah Zhang, PhD4, Xiwei Wu, PhD5*, SonBinh Nguyen, Ph.D.6*, Christiane Querfeld, MD, PhD7, David A Horne, PhD8*, Steve T Rosen, MD9, Leo I. Gordon, MD2, Colby Shad Thaxton, MD, PhD10* and Adam Yuh Lin, MD, PhD2

1Simpson Querrey Institute for Bionanotechnology, Northwestern University, Chicago, IL
2Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
3Northwestern University, Feinberg School of Medicine, Chicago, IL
4Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
5Department of Molecular and Cellular Biology, City of Hope, Duarte, CA
6Northwestern University, Evanston, IL
7Division of Dermatology, City of Hope, Duarte, CA
8Department of Molecular Medicine, Beckman Research Institute, City of Hope, Duarte, CA
9City of Hope Medical Center, Duarte, CA
10International Institute for Nanotechnology, Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL

Constanze Schneider, PhD1,2*, Hermes Spaink1,2*, Gabriela Alexe, PhD1,2*, Neekesh V Dharia, MD, PhD1,2*, Ashleigh Meyer1*, Delan Khalid1*, Sebastian Scheich, MD3,4*, Björn Häupl, PhD5,6*, Louis M. Staudt, MD, PhD4, Thomas Oellerich, MD3,5* and Kimberly Stegmaier, MD1,2

1Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA
2Broad Institute of MIT and Harvard, Cambridge, MA
3Department of Medicine II, Department for Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany
4Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
5German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany
6Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe-University, Frankfurt, Germany

Fiorella Charles Cano1*, Arnold Kloos, PhD1*, Rucha Yeshwanta Hebalkar, M.Sc.2*, Razif Gabdoulline, PhD3*, Thomas Fangmann1*, Yosef Landesman, PhD4*, Konstanze Döhner, MD5, Halyna R Shcherbata, PhD2*, Arnold Ganser, MD3* and Michael Heuser, MD1

1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Institute of Cell Biochemistry, Hannover Medical School, Hanover, Germany
3Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany
4Karyopharm Therapeutics Inc., Newton, MA
5Division of Hematology and Oncology, University Hospital Ulm, Ulm, Germany

Jianli Zhou1*, Aditya Kulkarni, Ph.D.1*, Cassandra Love2, Lanie Happ3*, Drew Sturtevant, Ph.D.1*, Neha Biyani, Ph.D.1*, Raniero L. Peru y Colón De Portugal, Ph.D.1*, Kishor Bhatia, Ph.D.1* and Sandeep S. Dave, MD, MS4

1Lantern Pharma Inc., Dallas, TX
2Duke University Medical Center, Durham, NC
3Data Drive Biosciences, Durham, NC
4Duke Cancer Institute, Duke University, Durham, NC

Xinguo Liu, PhD1*, Yubo Zhou2*, Yizhe Wu1*, Xiaomin Luo2*, Jiangfeng Xie1*, Xinxin Jin1*, Haiyan Yang, PhD3, Li Jia2* and Xinglu Zhou1*

1Hangzhou HealZen Therapeutics Co., Ltd., Hangzhou, China
2Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
3Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China

Maura Lima Pereira Bueno, undergraduate1*, Leonardo Artico2*, Adriana Silva Santos Duarte, Ph.D.1*, Audrey Basso, M.Sc.3*, Jose Andres Yunes, Ph.D.2*, Sara T Olalla Saad, MD, Ph.D.4 and Fernanda Marconi Roversi, PhD1*

1Hematology and Transfusion Medicine Center- University of Campinas/Hemocentro-UNICAMP, Campinas, São Paulo, Brazil
2Boldrini Children’s Center, Campinas, SP, Brasil, Campinas, Brazil
3Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
4Hematology and Transfusion Medicine Center-University of Campinas/Hemocentro-UNICAMP,, UNICAMP, Campinas, Brazil

Marta M. Szmyra1*, Sandra Haingartner1*, Sonja Jantscher1*, Katrin Pansy1*, Barbara Uhl1*, Hildegard T. Greinix, MD1, Peter Neumeister, MD1*, Eva Bernhart2*, Christine Beham-Schmid3*, Michael A. Dengler4*, Burkhard Klösch5* and Alexander J.A. Deutsch1*

1Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
2Division of Molecular Biology and Biochemistry, Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz, Graz, Austria
3Institute of Pathology, Medical University of Graz, Graz, Austria
4Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
5Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Graz, Austria

Chi-Yang Tseng1, Yu-Hsuan Fu, M.S.1,2*, Ang-Chu Huang, M.S.1*, Da-Liang Ou, PhD3*, Ching-Ying Kuo, Ph.D.1* and Liang-In Lin, PhD1

1Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan
2Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
3Department of Oncology, National Taiwan University, Taipei, Taiwan

John Dalloul1,2*, Minyoung Youn, Ph.D.3*, Kailen Mark3*, Alexander Powers1,4*, Ron Dror, Ph.D.1*, Soichi Wakatsuki, Ph.D.5,6* and Kathleen M. Sakamoto, MD, PhD3

1Department of Computer Science, Stanford University, Stanford
2Department of Bioengineering, Stanford University, Stanford, CA
3Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
4Department of Chemistry, Stanford University, Stanford
5BioSciences Division, SLAC National Accelerator Laboratory, Menlo Park
6Department of Structural Biology, Stanford University School of Medicine, Stanford

Sean M Post, PhD1, Lauren E Chan2*, Xiaorui Zhang, MS2*, Oscar Benitez2*, Kerstin Rahn3*, Todd Link, PhD4*, Clifford Stephan5*, Eun Cho, PhD6*, Kevin Dalby6* and Prerna Malaney, BPharm, MS, PhD7*

1Department of Leukemia, MD Anderson, Houston, TX
2MD Anderson, Houston
3Department of Intensive Care Medicine, University Hospital RWTH Aachen University, Aachen, Germany
4Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
5Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX
6UT Austin, Austin
7Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Haixiang Yu, PhD1, Juliana Layzer, MS1*, Sriram Krishnaswamy, PhD2 and Bruce A. Sullenger, PhD1*

1Department of Surgery, Duke University Medical Center, Durham, NC
2Research Institute, Children's Hospital of Philadelphia, Philadelphia, PA

Jian-Ming LI, PhD1,2*, Tenzin Passang3*, Pankoj Kumar Das3*, Shuhua Wang, MD4*, Anish Sen-Majumdar, Ph.D.5*, Nikolaos Papadantoonakis, MD6*, Cynthia R. Giver, PhD7 and Edmund K. Waller, MD, PhD2,8

1Winship Cancer Inst. Emory University, Atlanta, GA
2Winship Cancer Institute, Emory University, Atlanta, GA
3Winship Cancer Institute Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
4Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Decatur, GA
5Cambium Oncology, Atlanta, GA
6Winship Cancer Institute, Hematology/Medical Oncology, Emory University, Atlanta, GA
7Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
8Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA

Manickam Alagar, Ph.D1*, Biaoru Li, MD, PhD1, Santhosh Vadivelu2*, Robert Schaub3*, Chithra D Palani, PhD1 and Betty S. Pace, MD4,5

1Department of Pediatrics, Augusta University, Augusta, GA
2AkiraBio Inc.,, Wellesley, MA
3AkiraBio Inc.,, Wellesley,, MA
4Department of Pediatrics, Division of Hematology/Oncology, Augusta University, Augusta, GA
5Georgia Cancer Center, Augusta University, Augusta, GA

*signifies non-member of ASH